XELJANZ XR (tofacitinib extended-release) Patient Assistance Program
Don’t let the high cost of brand once-daily JAK inhibitor therapy disrupt your treatment. We help eligible patients access Xeljanz XR (tofacitinib extended-release) for as little as $69.95 per month through the manufacturer’s Patient Assistance Program.
- Clear & Transparent Pricing
- Paperwork & Doctor-Coordination
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-certification And Refills Management
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Xeljanz XR (tofacitinib extended-release) is the once-daily formulation of tofacitinib — FDA-approved for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ulcerative colitis, ankylosing spondylitis. Same active drug as Xeljanz IR (twice-daily) with simpler once-daily dosing.
- Without assistance, Xeljanz XR costs commonly run approximately $5,200–$6,200 per 30-day supply.
- Through AffordMyPrescriptions, qualifying patients can access Xeljanz XR for a flat $69.95 per month.
- Generic tofacitinib (IR, twice-daily) now available — substantially cheaper than brand Xeljanz/Xeljanz XR. Generic XR availability varies. Other JAK inhibitors (Olumiant, Rinvoq) all carry similar boxed warnings. TNF biosimilars often preferred over JAK inhibitors per current safety data.
What Is Xeljanz XR Prescription Assistance Program?
Xeljanz XR PAP for autoimmune/IBD patients.
Eligibility, rheum/GI coordination.
AffordMyPrescriptions eliminates that burden. $69.95/month advocacy.
Pharmacy Price Comparison
- Xeljanz XR $5,200–$6,200/month. Generic tofacitinib IR much cheaper:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens (brand) | ~$6,000 | Save substantially |
| CVS Pharmacy (brand) | ~$6,200 | Save substantially |
| Walmart (brand) | ~$5,400 | Save substantially |
| Costco (brand) | ~$5,300 | Save substantially |
Generic tofacitinib | ~$1,500 | Generic IR alt |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Xeljanz XR Prescription Program?
Generic tofacitinib IR substantially cheaper than Xeljanz XR. TNF biosimilars often preferred for safety profile (ORAL Surveillance).
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Xeljanz XR:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $5,200–$6,200 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Xeljanz XR assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Xeljanz XR Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured, Underinsured, Or A Medicare Part D Beneficiary
- You Have Recently Experienced A Change In Financial Circumstances That Affects Your Ability To Pay
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Xeljanz XR:
Xeljanz XR is once-daily tofacitinib — same active drug as Xeljanz IR (twice-daily). JAK inhibitor blocking JAK1/JAK3.
How Xeljanz XR Works:
Many inflammatory cytokines signal through JAK-STAT pathway. JAK inhibitors block multiple cytokine signaling, providing broad immunomodulation. JAK1/JAK3-preferring tofacitinib.
XR formulation simplifies adherence. Same indications and safety profile as IR. ORAL Surveillance trial showed higher CV/cancer/mortality vs TNF inhibitors in RA patients ≥50 with risk factors — TNF inhibitors generally preferred in such patients.
Form and use:
Xeljanz XR 11 mg once daily by mouth, with or without food. Different doses for different indications.
Generic availability:
Generic tofacitinib IR (5 mg twice daily) available. Generic XR availability variable. Other JAK inhibitors: Olumiant (baricitinib), Rinvoq (upadacitinib), Cibinqo (abrocitinib), Litfulo (ritlecitinib). TNF biosimilars (adalimumab, infliximab biosimilars) and other biologics often preferred per current safety data.
Warnings:
BOXED WARNINGS (JAK inhibitor class): serious infections (TB, fungal — screen before use), mortality (higher in RA patients ≥50 with CV risk factors per ORAL Surveillance), malignancies (lymphoma, lung cancer, NMSC), major adverse cardiovascular events, thrombosis (DVT, PE, arterial). Other: GI perforation, lab abnormalities, hypersensitivity.
FAQ (Frequently Asked Questions)
Cost ?
Brand $5,200–$6,200/month. Generic tofacitinib IR $1,500/month — significant savings.
Why JAK inhibitors with all the warnings?
ORAL Surveillance (2022) showed JAK inhibitors carry higher rates of CV events, malignancies, and mortality vs TNF inhibitors in older RA patients with CV risk factors. TNF biosimilars often preferred unless contraindicated. JAK inhibitors still useful but with informed consent and patient selection.
Should I switch to TNF biosimilar?
Discuss with rheumatologist/GI. For most older RA patients with CV risk, TNF biosimilars (adalimumab, infliximab biosimilars) generally preferred. For UC, infliximab biosimilar or Entyvio common alternatives.
XR vs IR?
Once daily vs twice daily — adherence. Generic IR much cheaper.
Denied?
Generic tofacitinib IR much cheaper. TNF biosimilar (Humira biosimilars, Remicade biosimilars) alternatives.
Take Control of Your Medication Costs
Generic tofacitinib IR substantially cheaper. TNF biosimilar often preferred per current safety data. Check eligibility today.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.